Dyslipidemia in renal disease: causes, consequences and treatment.
The prevalence of chronic renal insufficiency and its complications, including dyslipidemia, is increasing. Although the characteristics of dyslipidemia in chronic renal insufficiency and its pathophysiology are well known, its cardiovascular and renal impact and the most effective therapeutic approach are poorly defined.
Mesquita
Joana
J
Endocrinology Department, Hospital de São João-EPE, Portugal. joanamesquita1@gmail.com
Varela
Ana
A
Medina
José Luís
JL
D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy; D050171:Dyslipidemias / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000378:metabolism
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors